HDAC1 and non-small cell lung carcinoma: In the same model of NSCLC, it has been reported that the knockdown of HDAC1 sensitize resistant cells to paclitaxel in vitro and that SNOH-3, a selective HDAC1 inhibitor, induces apoptosis and suppresses angiogenesis in preclinical models [148].